Clearside Biomedical, Inc. CLM.SG Stock
Clearside Biomedical, Inc. Price Chart
Clearside Biomedical, Inc. CLM.SG Financial and Trading Overview
| Clearside Biomedical, Inc. stock price | 1.16 EUR |
| Previous Close | 0.82 EUR |
| Open | 0.84 EUR |
| Bid | 0.87 EUR x 0 |
| Ask | 0.93 EUR x 0 |
| Day's Range | 0.84 - 0.87 EUR |
| 52 Week Range | 0.62 - 1.52 EUR |
| Volume | 0 EUR |
| Avg. Volume | 27 EUR |
| Market Cap | 53.98M EUR |
| Beta (5Y Monthly) | 2.176 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.49 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.6 EUR |
CLM.SG Valuation Measures
| Enterprise Value | 22.84M EUR |
| Trailing P/E | N/A |
| Forward P/E | -2.217949 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 24.415966 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.328 |
| Enterprise Value/EBITDA | -0.763 |
Trading Information
Clearside Biomedical, Inc. Stock Price History
| Beta (5Y Monthly) | 2.176 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.52 EUR |
| 52 Week Low | 0.62 EUR |
| 50-Day Moving Average | 0.79 EUR |
| 200-Day Moving Average | 0.96 EUR |
CLM.SG Share Statistics
| Avg. Volume (3 month) | 27 EUR |
| Avg. Daily Volume (10-Days) | 181 EUR |
| Shares Outstanding | 62.41M |
| Float | 53.95M |
| Short Ratio | N/A |
| % Held by Insiders | 7.20% |
| % Held by Institutions | 27.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -821.18% |
| Gross Margin | 74.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.61% |
| Return on Equity (ttm) | -1310.022% |
Income Statement
| Revenue (ttm) | 2.21M EUR |
| Revenue Per Share (ttm) | 0.04 EUR |
| Quarterly Revenue Growth (yoy) | 222.90% |
| Gross Profit (ttm) | 1.12M EUR |
| EBITDA | -29930000 EUR |
| Net Income Avi to Common (ttm) | -37316000 EUR |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.8M EUR |
| Total Cash Per Share (mrq) | 0.46 EUR |
| Total Debt (mrq) | 1.09M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.281 |
| Book Value Per Share (mrq) | -0.207 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24237000 EUR |
| Levered Free Cash Flow (ttm) | -21662500 EUR |
Profile of Clearside Biomedical, Inc.
| Country | Germany |
| State | GA |
| City | Alpharetta |
| Address | 900 North Point Parkway |
| ZIP | 30005 |
| Phone | 678 270 3631 |
| Website | https://clearsidebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical, Inc. has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Q&A For Clearside Biomedical, Inc. Stock
What is a current CLM.SG stock price?
Clearside Biomedical, Inc. CLM.SG stock price today per share is 1.16 EUR.
How to purchase Clearside Biomedical, Inc. stock?
You can buy CLM.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Clearside Biomedical, Inc.?
The stock symbol or ticker of Clearside Biomedical, Inc. is CLM.SG.
Which industry does the Clearside Biomedical, Inc. company belong to?
The Clearside Biomedical, Inc. industry is Biotechnology.
How many shares does Clearside Biomedical, Inc. have in circulation?
The max supply of Clearside Biomedical, Inc. shares is 75.07M.
What is Clearside Biomedical, Inc. Price to Earnings Ratio (PE Ratio)?
Clearside Biomedical, Inc. PE Ratio is now.
What was Clearside Biomedical, Inc. earnings per share over the trailing 12 months (TTM)?
Clearside Biomedical, Inc. EPS is -0.49 EUR over the trailing 12 months.
Which sector does the Clearside Biomedical, Inc. company belong to?
The Clearside Biomedical, Inc. sector is Healthcare.